FERRI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.737
AS - Asia 10.624
EU - Europa 5.523
AF - Africa 2.165
SA - Sud America 2.070
Continente sconosciuto - Info sul continente non disponibili 492
OC - Oceania 205
Totale 41.816
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.480
SG - Singapore 2.994
IT - Italia 1.682
CN - Cina 1.638
VN - Vietnam 1.306
BR - Brasile 1.266
HK - Hong Kong 1.075
BD - Bangladesh 735
FR - Francia 425
FI - Finlandia 394
IN - India 354
CA - Canada 269
DE - Germania 262
PL - Polonia 261
GB - Regno Unito 258
RU - Federazione Russa 213
IQ - Iraq 211
NL - Olanda 185
AR - Argentina 180
SE - Svezia 168
CI - Costa d'Avorio 165
TR - Turchia 154
PK - Pakistan 146
JP - Giappone 139
SA - Arabia Saudita 131
MX - Messico 124
PH - Filippine 117
ID - Indonesia 116
ZA - Sudafrica 108
UA - Ucraina 99
UZ - Uzbekistan 96
ES - Italia 92
KR - Corea 90
EG - Egitto 89
EC - Ecuador 88
AT - Austria 87
CO - Colombia 87
IE - Irlanda 87
TH - Thailandia 87
PE - Perù 81
MY - Malesia 80
VE - Venezuela 80
JM - Giamaica 71
CL - Cile 70
AL - Albania 69
BJ - Benin 69
DZ - Algeria 69
KE - Kenya 69
CZ - Repubblica Ceca 67
KG - Kirghizistan 67
IL - Israele 65
AO - Angola 63
CH - Svizzera 63
MA - Marocco 63
PY - Paraguay 63
TN - Tunisia 63
JO - Giordania 62
LY - Libia 62
GR - Grecia 61
HN - Honduras 61
ML - Mali 61
RS - Serbia 61
TW - Taiwan 61
AZ - Azerbaigian 60
CY - Cipro 59
DK - Danimarca 59
MU - Mauritius 58
BY - Bielorussia 57
CR - Costa Rica 57
AE - Emirati Arabi Uniti 56
DO - Repubblica Dominicana 56
NP - Nepal 56
LA - Repubblica Popolare Democratica del Laos 55
NI - Nicaragua 55
TJ - Tagikistan 55
BO - Bolivia 54
GF - Guiana Francese 54
GM - Gambi 54
HR - Croazia 53
LV - Lettonia 53
NO - Norvegia 53
PS - Palestinian Territory 53
BG - Bulgaria 52
ET - Etiopia 52
HU - Ungheria 52
LB - Libano 52
MD - Moldavia 52
MK - Macedonia 52
PR - Porto Rico 52
RO - Romania 52
AU - Australia 51
MN - Mongolia 51
PA - Panama 51
SN - Senegal 51
TT - Trinidad e Tobago 51
XK - ???statistics.table.value.countryCode.XK??? 51
SK - Slovacchia (Repubblica Slovacca) 50
BA - Bosnia-Erzegovina 49
IR - Iran 49
BE - Belgio 48
Totale 39.034
Salva come PNG Salva come JPEG
Città #
Ashburn 2.659
Fairfield 2.137
Singapore 1.761
Woodbridge 1.397
San Jose 1.236
Houston 1.141
Hong Kong 960
Seattle 845
Ann Arbor 809
Cambridge 739
Wilmington 721
Chandler 416
Ho Chi Minh City 414
Los Angeles 352
Boardman 338
Santa Clara 335
Hanoi 300
Council Bluffs 285
New York 278
Beijing 251
San Diego 219
Lauterbourg 218
Dallas 208
Princeton 197
Medford 192
Roxbury 172
Padova 170
Milan 169
Bytom 164
Helsinki 164
Abidjan 161
Des Moines 153
Chicago 128
Guangzhou 114
São Paulo 106
Rome 104
Buffalo 86
Tashkent 84
Tokyo 81
Baghdad 80
Nanjing 78
Orem 76
Hefei 75
Denver 73
Da Nang 72
Munich 70
San Francisco 67
Atlanta 66
Cotonou 65
Montreal 65
London 64
Dong Ket 63
Dublin 61
Phoenix 61
Brooklyn 59
Vienna 57
Amman 56
Bishkek 56
Lima 53
Luanda 53
Nairobi 53
Warsaw 53
Baku 52
Bamako 52
Lappeenranta 52
Dakar 51
Managua 51
Dushanbe 50
Ulan Bator 50
Riga 49
Kingston 47
Panama City 47
Bangkok 46
Haiphong 46
Libreville 46
Toronto 46
Vientiane 46
Addis Ababa 45
Jeddah 45
Nuremberg 45
Kampala 44
Padua 44
San José 44
Riyadh 42
Accra 41
Harare 41
Kigali 41
Nassau 41
Shanghai 41
Belo Horizonte 40
Castries 40
Havana 40
Lahore 40
Naples 40
Phnom Penh 40
Bridgetown 39
Cairo 39
Dili 39
Montevideo 39
Nouakchott 39
Totale 23.420
Salva come PNG Salva come JPEG
Nome #
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 773
Pharmacokinetics, Tolerability, and Safety of Esmethadone in Subjects with Chronic Kidney Disease or Hepatic Impairment 528
The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD 508
Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine/enalapril 472
The emerging role of nutraceuticals in cardiovascular calcification: Evidence from preclinical and clinical studies 411
Multidisciplinary studies on a sperm whales’ mass stranding. 406
Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice 390
L-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cells 366
Effects of Handroanthus impetiginosus (Mart. ex DC.) Mattos extract on inflammatory, immune, atherogenic profile and differentiation in THP-1 cell line 322
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 288
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line 285
New RAC1 inhibitors as potential pharmacological agents for heart failure treatment 278
Mitochondrial depletion of glutaredoxin 2 induces metabolic dysfunction associated fatty liver disease in mice. 277
Bempedoic Acid, the First-in-Class Oral ATP Citrate Lyase Inhibitor with Hypocholesterolemic Activity: Clinical Pharmacology and Drug–Drug Interactions 261
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: analysis on cytokines and lipid profile 260
Pharmacokinetics interactions of monoclonal antibodies 255
In Vitro and In Vivo Sucrosomial® Berberine Activity on Insulin Resistance 255
Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients 252
Current evidence and future perspectives on pharmacological treatment of calcific aortic valve stenosis 247
Suppressor of Cytokine Signaling-3 (SOCS-3) induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) expression in hepatic HepG2 cell line 234
From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients 234
PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma 232
Bioactive alkaloids from Nepalese Corydalis chaerophylla D.C. acting on the regulation of PCSK9 and LDL-R in vitro 231
Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation 231
Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model 230
Pharmacology of the New P2Y(12) Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties 230
Geranylgeraniol prevents the simvastatin-induced PCSK9 expression: role of the small G protein Rac1 226
NMR, LC-MS Characterization of Rydingia michauxii Extracts, Identification of Natural Products Acting as Modulators of LDLR and PCSK9 226
Lipid Lowering Drugs and Inflammatory Changes: an Impact on Cardiovascular Outcomes? 224
Investigating the in vitro mode of action of okra (Abelmoschus esculentus) as hypocholesterolemic, anti-inflammatory, and antioxidant food 223
17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy 221
Differential Processing of α- and β-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7) 221
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders 221
3-Aryl-N-aminoylsulfonylphenyl-1H-pyrazole-5-carboxamides : a new class of selective Rac inhibitors 220
Bergamot (Citrus bergamia) peel extract as new hypocholesterolemic agent modulating PCSK9 expression 218
The Cost of Atrial Fibrillation: A Systematic Review 218
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: new therapeutic approaches for the treatment of atherogenic dyslipidemia 216
A selective alpha1D-adrenoreceptor antagonist inhibits human prostate cancer cell proliferation and motility "in vitro" 213
Nitric Oxide-Donating Atorvastatin Attenuates Neutrophil Recruitment During Vascular Inflammation Independent of Changes in Plasma Cholesterol 213
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 212
Himalayan Nettle Girardinia diversifolia as a Candidate Ingredient for Pharmaceutical and Nutraceutical Applications-Phytochemical Analysis and In Vitro Bioassays 212
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 211
Gene Silencing of Angiopoietin-like 3 (ANGPTL3) Induced De Novo Lipogenesis and Lipid Accumulation in Huh7 Cell Line 210
Peptidomimetic inhibitors of farnesyltransferase with high in vitro activity and significant cellular potency 209
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin 209
An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties 209
Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits 208
A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH 207
Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer's Disease 207
The Glycolytic Enzyme PFKFB3 Is Involved in Estrogen-Mediated Angiogenesis via GPER1 206
AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular disease 206
Liver fat accumulation is associated with circulating PCSK9 levels 205
Legacy perfluoro-alkyl substances impair LDL-cholesterol uptake independently from PCSK9-function 204
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study 204
Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells 203
The Modulation of PCSK9 and LDLR by Supercritical CO2 Extracts of Mentha longifolia and Isolated Piperitone Oxide, an In Vitro Study 202
Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis 200
Virtual screening approach for the identification of new Rac1 inhibitors 199
Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism 198
Cytotoxic Pt(ii) complexes containing alizarin: a selective carrier for DNA metalation 198
Synthesis, Structural and Biological Evaluation of Bis-Heteroarylmaleimides and Bis-Heterofused Imides 196
Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits 194
Isothiazole dioxide derivative 6n inhibits vascular smooth muscle cell proliferation and protein farnesylation 194
PCSK9 induces a pro-inflammatory response in macrophages 193
The brown algae fucus vesiculosus and ascophyllum nodosum reduce metabolic syndrome risk factors: A clinical study 193
Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells 190
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation 189
Development of poly(lactide-co-glycolide) nanoparticles functionalized with a mitochondria penetrating peptide 187
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer's Disease 186
Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals 186
Evaluation of the effects of natural isoquinoline alkaloids on low density lipoprotein receptor (LDLR) and proprotein convertase subtilisin/kexin type 9 (PCSK9) in hepatocytes, as new potential hypocholesterolemic agents 186
Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages 184
Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis 184
xIAP induces cell-cycle arrest and activates nuclear factor-kappaB : new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells 184
Thematic review series : the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease 183
Drug attrition during pre-clinical and clinical development : understanding and managing drug-induced cardiotoxicity 183
Isothiazoles. Part XV. A mild and efficient synthesis of new antiproliferative 5-sulfanylsubstituted 3-alkylaminoisothiazole 1,1-dioxides 182
Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects 182
Non-lipid-related effects of statins 181
Direct vascular effects of HMG-CoA reductase inhibitors 180
Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells 180
Monofunctional PtII Complexes Based on 8-Aminoquinoline: Synthesis and Pharmacological Characterization 180
Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE Study 180
Identification of Ellagitannins in the Unripe Fruit of Rubus Chingii Hu and Evaluation of its Potential Antidiabetic Activity 179
Differential effects of red yeast rice, Berberis aristata and Morus alba extracts on PCSK9 and LDL uptake 178
Clinical approach to the inflammatory etiology of cardiovascular diseases 178
PCSK9 promotes arterial medial calcification 178
Bococizumab for the treatment of hypercholesterolaemia 177
Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats 177
Upregulation of Lectin-Like Oxidized Low Density Lipoprotein Receptor 1 (Lox-1) Expression in Human Endothelial Cells by Modified High Density Lipoproteins 176
Adipose tissue related adipokines and cytokines regulate PCSK9 expression in HepG2 cells 176
Proprotein convertase subtilisin kexin type 9 and high-density lipoprotein metabolism: experimental animal models and clinical evidence 175
Cytotoxic performances of new anionic cyclometalated Pt(II) complexes bearing chelated O^O ligands 175
Clinical Pharmacology of Factor XI Inhibitors: New Therapeutic Approaches for Prevention of Venous and Arterial Thrombotic Disorders 174
Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain 173
Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression 172
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain 172
SUPPRESSOR OF CYTOKINE SIGNALING-3 (SOCS-3) INDUCES PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) EXPRESSION IN HEPATIC HEPG2 CELL LINE 171
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 171
Antiproliferative effects on human tumor cells and rat aortic smooth muscular cells of 2,3-heteroarylmaleimides and heterofused imides 171
Totale 22.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.360
article - articoli 100.080
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 444
selected - selezionate 0
volume - volumi 343
Totale 214.227
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.501 0 260 326 186 125 113 128 297 139 78 231 618
2022/20231.364 348 20 14 125 265 151 27 114 183 14 77 26
2023/20241.121 31 91 107 85 38 38 49 291 89 41 126 135
2024/20254.516 34 197 143 110 498 88 219 366 630 272 798 1.161
2025/202620.729 633 1.727 3.076 3.494 1.453 865 2.082 1.875 1.752 1.255 1.519 998
2026/20273.338 2.159 1.179 0 0 0 0 0 0 0 0 0 0
Totale 41.816